Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziji Yu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Blood Neoplasia|June 24, 2025
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myelomaAmrita Y Krishnan, Krina K Patel, Meera Mohan, et al.
Drug and Alcohol Dependence|October 5, 2021
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening testGerald Cochran, Jennifer Brown, Ziji Yu, et al.
Addictive Behaviors Reports|February 27, 2023
Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorderElizabeth Charron, Ziji Yu, Brad Lundahl, et al.
Addiction (Abingdon, England)|October 20, 2023
Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trialGerald Cochran, Marcela C Smid, Elizabeth E Krans, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2025
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 studyAlberto Sobrero, Arvind Dasari, Jeneth Aquino, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Blood Neoplasia|June 24, 2025
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myelomaAmrita Y Krishnan, Krina K Patel, Meera Mohan, et al.
Drug and Alcohol Dependence|October 5, 2021
Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening testGerald Cochran, Jennifer Brown, Ziji Yu, et al.
Addictive Behaviors Reports|February 27, 2023
Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorderElizabeth Charron, Ziji Yu, Brad Lundahl, et al.
Addiction (Abingdon, England)|October 20, 2023
Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trialGerald Cochran, Marcela C Smid, Elizabeth E Krans, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2025
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 studyAlberto Sobrero, Arvind Dasari, Jeneth Aquino, et al.
Pageof 2